More than 6749 items endorsed by the best medical specialists

The localised treatment of prostate cancer with prostate seed (LDR) brachytherapy

Prostate cancer begins in the prostate gland. Traditional treatment methods for prostate cancer can cause damage to the surrounding tissues, which can result in further urinary problems. Another option is using LDR seed brachytherapy, which treats prostate cancer in a localised manner, protecting nearby tissue. Highly skilled consultant clinical oncologist Dr Albert Edwards, based in Canterbury and Maidstone, explains what LDR brachytherapy is and what to expect from the procedure.

Early-stage lung cancer: Screening, diagnosis and treatment

Lung cancer is a common cause of death from cancer in the UK, affecting more than 47,000 people every year. While the long-term outlook improves every day from improvements in treatment of advanced disease, detection and treatment of cancer in its earliest stage(s) remains key for prognosis. Here, Dr Crispin Hiley, highly esteemed consultant clinical oncologist, provides a comprehensive overview of early-stage lung cancer.

Chemotherapy and breast cancer: an expert insight

Here, find out how effective chemotherapy can be for patients who are undergoing treatment for breast cancer, how often chemotherapy is required for patients with the illness, and what exactly patients can expect in the chemotherapy process, as highly revered consultant clinical oncologist, Dr Apurna Jegannathen, gives us a comprehensive all-you-need-to-know guide.

Psoriasis, keloid scarring, arthritis and many more: Could radiotherapy be the answer?

Radiotherapy, traditionally used to treat cancer, can also be beneficial to patients with benign conditions such as psoriasis, arthritis and keloid scarring. In this illuminating article, highly respected radiotherapy specialist and consultant clinical oncologist Dr Richard Shaffer gives an expert guide to radiotherapy for benign conditions.

Extended genomic testing explained

Extended genomic testing is the process by which alterations, copies and mutations in genes are analysed. The reach of this type of testing has developed greatly in recent years and it now has many applications. One such application is in assessing and treating brain tumours, as the results give doctors the specefic information they need in order to target treatment as effectively as possible. In this article, renowned consultant clinical oncologist and researcher Dr Matthew Williams explains the science behind this innovative type of testing and how it can be used to achieve improved outcomes for patients.

Showing results 40 of 59


This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.